Mesoblast’s RYONCIL ® (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA approved mesenchymal ...
It’s not HBO, it’s Max — but the new logo for Warner Bros. Discovery’s streamer now certainly looks like HBO’s at a glance.
Holzbrecher-Morys from the German Hospital Federation explains what the hospital reform means for hospitals in terms of ...